What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy

Open

SPC manufacturing waiver

24 October 2017

Policy

SME Intergroup Conclusions – Boosting SMEs through the SPC Waiver […]

Read more

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

Read more

2017 Market Review – Biosimilar Medicines Markets – Policy Overview

12 September 2017

Report

Open

Biosimilars — Can the dream of affordable cancer care come true?

8 September 2017

External Resource

Open

A Clinician´s Guide to Biosimilars in Oncology: Understanding the Science of Extrapolation and Interchangeability

8 September 2017

External Resource

Open

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Read more

The Benefits of Biosimilar Medicines

20 June 2017

Infographic

Open

Join Medicines for Europe – 2017

15 June 2017

Video

View

Global Healthcare Trends and Outlook

15 June 2017

Report

Open

Subscribe to our newsletter